Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR

BACKGROUND: Triple-negative breast cancer (TNBC) is a biologically diverse disease, with characteristics such as homologous recombination deficiency (HRD), gene mutation, and immune reactions. Japan Breast Cancer Research Group 22 is a multicenter trial examining TNBC’s response to neoadjuvant chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Takayuki, Kitano, Shigehisa, Masuda, Norikazu, Ikarashi, Daiki, Yamashita, Makiko, Chiba, Tomohiro, Kadoya, Takayuki, Bando, Hiroko, Yamanaka, Takashi, Ohtani, Shoichiro, Nagai, Shigenori, Nakayama, Takahiro, Takahashi, Masato, Saji, Shigehira, Aogi, Kenjiro, Velaga, Ravi, Kawaguchi, Kosuke, Morita, Satoshi, Haga, Hironori, Ohno, Shinji, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036790/
https://www.ncbi.nlm.nih.gov/pubmed/35462552
http://dx.doi.org/10.1186/s12916-022-02332-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036790/
https://www.ncbi.nlm.nih.gov/pubmed/35462552
http://dx.doi.org/10.1186/s12916-022-02332-1

Ejemplares similares